Dietary Strategies to Modulate Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Nutrients · 01.06.2025 · 17 (11) · 1906
DOI: 10.3390/nu17111906 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 01.06.2025. Verfasst von Federica Perazza und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Fatty Liver, Diet, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gut microbiota has become an area of increasing interest for its potential role in metabolic dysfunction-associated steatotic liver disease (MASLD) and its more advanced form, metabolic dysfunction-associated steatohepatitis (MASH)—now recognized as the most frequent liver disease worldwide. Research suggests that imbalances in the intestinal microbiota, including dysbiosis and increased intestinal permeability, may contribute to the pathogenesis of MASLD and progression to MASH. These changes affect insulin resistance and trigger inflammatory responses by disrupting the gut–liver axis. This review examined the current evidence connecting gut microbiota to MASLD and MASH, exploring how microbial shifts might influence liver health. Emerging strategies—such as probiotics, prebiotics, and targeted dietary changes—that may help prevent or manage these conditions are also discussed. Finally, key areas where further studies are required to understand the role of microbiota and its therapeutic potential are highlighted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
- Department of Dietetics and Clinical Nutrition, Maggiore-Bellaria Hospital, Azienda Unità Sanitaria Locale (AUSL), 40138 Bologna, Italy.
- Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
- HandyDiet SRL, 24128 Bergamo, Italy.
- Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
- Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy.
ORCID-Profile: Federica Perazza, Alessia Bonalumi, Alice Beretta, Maria Letizia Petroni, Fabio Piscaglia, Federico Ravaioli, Michele Sculati
Zitieren
APA
Perazza, F., Leoni, L., Selvatici, B., Girolami, F., Bonalumi, A., Beretta, A., Ferri, S., Petroni, M. L., Piscaglia, F., Ravaioli, F., & Sculati, M. (2025). Dietary Strategies to Modulate Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Nutrients, 17(11), 1906. https://doi.org/10.3390/nu17111906
Vancouver
Perazza F, Leoni L, Selvatici B, Girolami F, Bonalumi A, Beretta A, et al. Dietary Strategies to Modulate Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Nutrients. 2025;17(11):1906. doi:10.3390/nu17111906
BibTeX
@article{Perazza2025,
author = {Perazza, Federica and Leoni, Laura and Selvatici, Beatrice and Girolami, Francesca and Bonalumi, Alessia and Beretta, Alice and Ferri, Silvia and Petroni, Maria Letizia and Piscaglia, Fabio and Ravaioli, Federico and Sculati, Michele},
title = {Dietary Strategies to Modulate Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {11},
pages = {1906},
doi = {10.3390/nu17111906}
}
EUVIMED